Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

BACKGROUND: Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV. To date, women have been less represented than...

Descripción completa

Detalles Bibliográficos
Autores principales: Benning, Lorie, Mantsios, Andrea, Kerrigan, Deanna, Coleman, Jenell S., Golub, Elizabeth, Blackstock, Oni, Konkle-Parker, Deborah, Philbin, Morgan, Sheth, Anandi, Adimora, Adaora A., Cohen, Mardge H., Seidman, Dominika, Milam, Joel, Kassaye, Seble G., Taylor, Tonya, Murray, Miranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382076/
https://www.ncbi.nlm.nih.gov/pubmed/32711509
http://dx.doi.org/10.1186/s12905-020-01011-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382076/
https://www.ncbi.nlm.nih.gov/pubmed/32711509
http://dx.doi.org/10.1186/s12905-020-01011-8

Ejemplares similares